SCHD’s 6 Basis Point Fee Hides a 38% Decade-Long Performance Gap

Photo of Michael Williams
By Michael Williams Published

Quick Read

  • SCHD's 0.06% fee is trivial, but its top 10 holdings eat 40% of assets, doubling exposure you likely already own elsewhere.

  • DGRW beat SCHD by 38% over the last decade, roughly $3,800 more per $10,000 invested, despite charging higher fees.

  • SCHD's annual March reconstitution cut Q2 2026 dividends to $0.25 from $0.82 the prior year, proving stable income is a myth.

  • Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
SCHD’s 6 Basis Point Fee Hides a 38% Decade-Long Performance Gap

© kody_king / Shutterstock.com

You bought Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) because the sticker price looked unbeatable: 6 basis points, a rounding error. But the fee is the cheapest part of this ETF. The expensive part is what you never see on the factsheet: the returns you left on the table, the ten stocks you accidentally over-own, and the tax bill triggered every March.

What you’re actually paying

Start with the actual number. SCHD’s 0.06% expense ratio works out to about $6 per year on every $10,000 invested. That is genuinely low. Compound $6 a year over 20 years and the fee still isn’t what’s holding your portfolio back.

The real drag is opportunity cost. Over the last decade, WisdomTree U.S. Quality Dividend Growth Fund (NASDAQ:DGRW) out-returned SCHD by 38%, and it did so while charging higher fees. Vanguard S&P 500 ETF (NYSEARCA:VOO) and Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) both carry heavier tech weightings and, in the current cycle, that mattered: Seeking Alpha downgraded SCHD to “Hold” on June 23, 2026, citing exactly this gap. On $10,000, a 38% decade-long shortfall is roughly $3,800 in foregone growth. That dwarfs the fee by three orders of magnitude.

SCHD returned 49.74% over the last five years and 220.6% over the last ten. Solid on its own. Underwhelming next to broad-market and quality-growth peers over the same window.

The part the factsheet doesn’t highlight

Look at what “diversified” means here. SCHD holds around 105 positions, but the top 10 alone represent approximately 40.56% of net assets. That includes Bristol-Myers Squibb at 4.26%, Merck at 4.14%, ConocoPhillips at 4.10%, and Altria at 3.97%. If you already own an S&P 500 fund, you are double-buying these names, not diversifying.

Then there is the reconstitution tax. SCHD rebuilds its book once a year. In March 2026, the fund added 25 stocks and removed 22, cutting energy exposure by roughly 8% while boosting healthcare, tech, and financials. Every swap in a taxable account is a realized event under the hood, and the reshuffle showed up in your paycheck: the Q2 2026 distribution came in lower than the year-ago quarter. Look at the receipts: $0.2525 on June 24, 2026 versus $0.8241 on June 26, 2024. Quarterly dividend income is not a stable line item, even in a fund marketed on stability.

One more line item marketing skips: sector concentration. Energy stocks make up 17% of the fund, well above the broader market. That is a cyclical bet embedded in a “defensive” wrapper.

The cheaper mirror

If you want raw dividend yield with wider diversification, Vanguard High Dividend Yield ETF (NYSEARCA:VYM) covers similar income exposure with a broader book. If you want the quality-and-growth angle SCHD advertises, DGRW beat it by 38% over the past decade. If you already own VOO or a total-market fund, understand that SCHD largely tilts what you already have toward energy and mature staples rather than adding new exposure. That tilt is the product. Decide whether you actually want it.

What this means for you

SCHD’s fees are cheap, but the fund is expensive on everything the fee doesn’t measure: opportunity cost against quality-growth peers, concentration in ten stocks doing 40% of the work, and a March reconstitution that quietly moves your tax bill and your dividend check. The real question is: what am I paying in return I’ll never see, to own a fund whose largest ten names I probably already own somewhere else?

Contact [email protected] for any questions or corrections.

Photo of Michael Williams
About the Author Michael Williams →

I am a long time investor and student of business, and believe finding good companies that can become great investments is the best game on earth. After 20 years of writing and researching the public markets it is clear that individuals have never had more tools and information to take control of their financial lives. From ETFs and $0 commissions to cryptos and prediction markets there has never been a greater democratization of access to investing. 

I write to help people understand the investments available to them so they can make the best choice for their portfolio, whether they're starting out or looking for income in retirement. 

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

GPC Vol: 5,088,383
MRNA Vol: 14,112,476
EFX Vol: 2,195,638
VRTX Vol: 1,879,133
SPGI Vol: 3,749,613

Top Losing Stocks

TER Vol: 5,938,036
KLA
KLAC Vol: 23,648,857
GLW Vol: 21,192,211
STX Vol: 6,302,838
LRCX Vol: 18,973,383